The World Market for Transdermal Drug Delivery

News provided by

Oct 08, 2012, 07:03 ET

NEW YORK, Oct. 8, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The World Market for Transdermal Drug Delivery

http://www.reportlinker.com/p01008895/The-World-Market-for-Transdermal-Drug-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Transdermal (and related transmucosal) drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. There is no potential limit for the therapeutic area for development of transdermal systems. Some therapeutic areas stand out, including sex hormones and pain management, due to the successful combination of the individual drug molecules and available product technologies. The potential benefits that may be achieved using transdermal delivery include continuous, controlled release and absorption of medication into the body, avoiding presystemic metabolism that may occur following oral dosing, including both intestinal and hepatic first-pass metabolism, improving patient compliance by offering more convenient dosing regimens , such as once or twice weekly dosing, and the ability to quickly discontinue treatment by removal of the system.

This report, World Markets for Transdermal Drug Delivery is a comprehensive look at the transdermal/transmucosal drug delivery market is divided into two sections. The first section encompasses the pharmaceutical products that utilize the drug delivery technology. The second section encompasses drug delivery technology and the revenues earned from licensing that technology. Because drug delivery technology is an integral part of sales of pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that include pharmaceutical sales for products utilizing that technology.

This market is divided into two segments:

Market Size and Forecast for Transdermal Drug Delivery

Market Size and Forecast for Transmucosal Drug Delivery

Market Breakout by Region (US, Europe, Japan, ROW)

Review of Products on the Market

Market Breakout by Disease Treated (Cardiovascular, Hormones, Pain Management, Smoking Cessation, Other)

Market Breakout by Technology Revenues and Pharmaceutical Component Revenues

Profiles of Companies in the Market

The research conducted by Kalorama included comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. New technologies, market developments, and research and development trends and expenditures were identified through patent and database searches, as well as via interviews with key personnel. Person-to-person and telephone interviews were the primary method of gathering information. E-mail correspondence was also used in the interview process. Interviews with 18 key industry officials, trade association representatives, consultants, healthcare providers, and government personnel were compiled to form the primary basis of information—particularly revenue and market share data—presented in this report.

All market data pertain to the worldwide market at the manufacturers' level and presented in U.S. dollars. The base year for data was 2012. Historical data are provided for 2010 through 2011, with forecast data provided for 2013 through 2017. Compound annual growth rates (CAGR) are provided for the 2010-2012, 2012-2017, and 2010–2017 periods.

CHAPTER ONE: EXECUTIVE SUMMARY

Market Drivers

Market Size and Growth

Total Transdermal/Transmucosal Drug Delivery Market

Transdermal/Transmucosal Drug Delivery Only Market

Competitive and Market Analysis

CHAPTER TWO: INTRODUCTION AND OVERVIEW

Scope and Methodology

Reasons for Transdermal/Transmucosal Drug Delivery Systems

Phases of Drug Action

Transdermal drug Delivery

History of Transdermal Drug Delivery

Advantages of Transdermal Drug Delivery

Disadvantages of Transdermal Drug Delivery

Transdermal Patch (Passive) Drug Delivery

Transfersomes

Medicated Tattoos

Crystal Reservoir Technology

Active Transdermal Drug Applications

Electrotransport Drug Delivery

Iontophoresis

Reverse Iontophoresis

Sonophoresis

Photomechanical Waves

Transmucosal Drug Delivery

Buccal Drug Delivery

Vaginal Drug Delivery

CHAPTER THREE: TRENDS AND DEVELOPMENTS

Novel Transdermal Approvals

Innovations in Transdermal Drug Delivery

Adhesive Technology and Issues

Adhesive Market Issues

Generic Transdermal Study Design Guidelines

Biotechnological Issues

Developments in Insulin Delivery

New Developments in Hormone Drug Delivery

New Mucosal/Buccal Delivery Systems

Other New Drug Delivery Systems

Microneedle-Assisted Transdermal Drug Delivery

Controlled Thermal Energy Technology

New Ultrasound Technology

Transdermal Products in Development

CHAPTER FOUR: MARKET SIZE AND GROWTH

The Total Transdermal/Transmucosal Drug Delivery Market

Transdermal/Transmucosal Delivery Technology Only Market

CHAPTER FIVE: COMPETITIVE ANALYSIS

Competitive Landscape

Emerging Participants

Market Analysis

CHAPTER SIX: COMPANY PROFILES

3M Pharmaceuticals

Access Pharmaceuticals, Inc.

Acrux Limited

ALZA Corporation

Antares Pharma, Inc.

Apricus BioSciences

Aveva Drug Delivery Systems

Generex Biotechnology Corporation

Inovio Pharmaceuticals, Inc.

Labtec GmbH

Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)

NITTO DENKO CORPORATION

Noven Pharmaceuticals, Inc.

Pantec Biosolutions AG

Tapemark

TEVA Pharmaceutical Industries Ltd.

Zosano Pharma

APPENDIX: COMPANY DIRECTORY

TABLE OF EXHIBITS

CHAPTER TWO: INTRODUCTION AND OVERVIEW

Table 2-2: Select Leading Transdermal Delivery-Based Products

CHAPTER THREE: TRENDS AND DEVELOPMENTS

Table 3-1: Selected Transdermal Products in Development

CHAPTER FOUR: MARKET SIZE AND GROWTH

Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2010-2017

Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2010-2017

Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmusal Drug Delivery Systems by Type 2010–2017

Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing\Transdermal/Transmucosal Drug Delivery Systems Revenues by Type 2010–2017

Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies Market Share by Type 2010-2017

Figure 4-3: Transdermal Drug Delivery Market by Disease Treated (Cardiovascular, Hormones, Pain Management, Smoking Cessation, Other)

Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Region (United States, Europe, Japan, ROW) 2010–2017

Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2010-2017

Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010-2017

Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010-2017

Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2012

Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2017

CHAPTER FIVE: COMPETITIVE ANALYSIS